印度食品安全与标准局（FSSAI）表示，雀巢印度生产的一款“低脂奶精”样本取自首都新德里康诺特广场拉利特酒店的经营场所，被认定“不安全且不合格”。不过，雀巢印度对此事回应称，其遵守所有适用的监管要求，其低脂奶精可以安全食用。该食品监管机构在社交媒体上发布消息称，样本采集自新德里康诺特广场 Bharat Hotels Ltd（The Lalit）的经营场所。
A sample of "low-fat dairy whitener" manufactured by Nestle India, drawn from the premises of Hotel Lalit in Connaught Place in the national capital, has been found "unsafe and substandard", the Food Safety and Standards Authority of India (FSSAI) said. However, responding to the development, Nestle India said it complies with all applicable regulatory requirements and its low-fat dairy whitener is safe to consume. In a post on social media, the food regulator said a sample was collected from the premises of Bharat Hotels Ltd (The Lalit), Connaught Place, New Delhi.
FSSAI称，食品分析实验室的报告认定该产品“不合格”且“不安全”，表明其违反了2006年《食品安全与标准法》（FSS法）的相关规定。该监管机构表示，实验室分析报告的副本已提供给食品经营者（FBO），供其参考并采取必要措施。监管机构还就这款不合规产品向 Bharat Hotels Ltd 发出通知。根据2006年《食品安全与标准法》的相关规定，FBO获准在规定期限内对食品分析报告提出申诉。
According to the FSSAI, the report of the food analyst's laboratory declared the product "substandard" and "unsafe", indicating non-compliance under the Food Safety and Standards (FSS) Act, 2006.A copy of the laboratory analysis report was provided to the food business operator (FBO) for reference and necessary action, the regulator said. A notice has also been issued to Bharat Hotels Ltd over the non-compliant product. The FBO was given an opportunity to appeal against the food analyst's report under the relevant section of the FSS Act, 2006, within the prescribed period.
FSSAI补充称，FBO还被要求立即停止销售被认定存在安全问题的食品。雀巢印度在一份声明中表示，其“低脂奶精可以安全食用，并遵守所有适用的监管要求”。
The FBO has also been directed to immediately stop the sale of the identified unsafe food product, the FSSAI added. Nestle India, in a statement, said its "Low Fat Dairy Whitener is safe to consume and complies with all applicable regulatory requirements.
磷是一种天然存在于牛奶中的营养素，因此所有乳基产品中都含有磷。报告进一步指出，FSSAI实验室报告将总磷含量与添加剂限量进行比较，没有考虑乳基配料所带来的大量天然磷贡献。
Phosphorus is a nutrient that occurs naturally in milk and is therefore present in all milk-based products." It further said FSSAI lab reports reflect total phosphorus against the additive limit, without accounting for the substantial natural phosphorus contribution from milk-based ingredients."
“根据FSSR规定的限量，包括按食用状态计算，我们产品中的添加磷完全符合规定。”该报告说，“我们一直按照法律规定的正当程序与主管部门保持沟通，并已提供该类别中其他同类或类似乳基产品的相关数据，以反映天然存在的磷。”上个月，FSSAI表示，已就相关产品不符合食品安全规范一事对雀巢印度提起法律行动。FSSAI检查了NAN Excella Pro Stage 1、Lactogen Pro 1及一款后续配方产品，以及电商平台上提供的宣传材料。
Our product is in full compliance for added phosphorus as per prescribed limits under FSSR, including for as-consumed basis," it said, adding, "We have been in continuous engagement with the authorities as per due process established under law and have shared data across other same/similar milk-based products in the category to reflect presence of naturally occurring phosphorus." Last month, FSSAI said it had initiated legal action against Nestle India over non-compliance with food safety norms in the products. It had examined NAN Excella Pro Stage 1, Lactogen Pro 1 and a follow-up formula, along with promotional material available on e-commerce platforms.